BCM
EXAS

Brasada Capital Management’s Exact Sciences EXAS Stock Holding History

Brasada Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-500
Closed -$32K – 189
2018
Q4 		$32K Hold
500
– – 0.01% 196
2018
Q3 		$39K Buy
+500
New +$32.6K 0.01% 219

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Brasada Capital Management's EXAS Position: Q1 2019 in Review

Brasada Capital Management sold out of Exact Sciences (EXAS) in Q1 2019, closing a stake of 500 shares — an estimated $32K sold.

Brasada Capital Management first reported a position in EXAS in Q3 2018 and held it in 2 quarters. The position peaked at $39K in Q3 2018. 424 funds tracked by Wall St. Rank hold EXAS as of Q1 2019.

  • Brasada Capital Management reported no remaining Exact Sciences position as of Q1 2019 after selling out during the quarter.
  • Brasada Capital Management sold 500 Exact Sciences shares in Q1 2019, an estimated $32K.
  • Brasada Capital Management first reported a position in Exact Sciences in Q3 2018 and held it in 2 quarters.
  • Brasada Capital Management's Exact Sciences position peaked at $39K in Q3 2018.
  • 424 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2019.

Based on Brasada Capital Management's 13F filing for Q1 2019, filed 6 May 2019.